<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To establish the prevalence of cyclooxygenase-2 (COX-2) expression in a large series of resected Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and associated <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath> and to correlate this expression with clinicopathological data and prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: COX-2 expression was assessed by immunohistochemistry in resected surgical specimens of 66 Barrett's <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and 32 cases of Barrett's mucosa (with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in 17 cases) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Epithelial expression of COX-2 protein was increased in Barrett's mucosa compared with <z:mpath ids='MPATH_458'>normal</z:mpath> oesophagus </plain></SENT>
<SENT sid="3" pm="."><plain>Epithelial expression of COX-2 was found in 91% of Barrett's specialized mucosa negative for <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 94% of Barrett's mucosa with <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and 97% of Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>COX-2 expression was significantly higher in the well-differentiated <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> when compared with the poorly differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>There was no significant correlation between COX-2 expression and the other pathological features of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Survival analysis showed no significant prognostic value for COX-2 </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our results confirm up-regulation of COX-2 in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>-metaplastic and dysplastic-and in Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Increased COX-2 expression did not differ during the progression from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> negative for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> to Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and is related to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> whose histology is well differentiated </plain></SENT>
<SENT sid="9" pm="."><plain>This suggests that enhanced expression of COX-2 may occur early during Barrett's-associated <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
</text></document>